People living with sickle cell disease in England are to benefit from quicker and more accessible treatment due to a £9m investment, the government has announced.
Apheresis services, which are a type of treatment that removes harmful components from a patient’s blood, are to improve across England through the funding of more specialist treatment centres. The funding will ensure the wider availability of machines that remove a patient’s sickled red blood cells and replace them with healthy donor cells.
More than 20 NHS trusts currently offer Spectra Optia technology, a treatment more effective than blood transfusions and having been shown to be highly effective in reducing complications such as iron overload.
The investment could save the NHS up to £12.9m every year thanks to a reduction in time spent in hospital for patients and the reduced need for other treatments, according to the government.
Wes Streeting, the health and social care secretary, said: “People living with rare conditions like sickle cell disease face immense everyday challenges, and can sometimes struggle to get the specialised care they need.
“To make our health service fit for the future, we have to harness the power of new technologies, and these machines provide a shining example of how our government is starting to make huge advancements in digital healthcare.
“Through our plan for change, this government will be the one that removes the barriers to getting the latest and best tech to our NHS frontline, so patients can access the best care available, closer to home.”
Source: The Guardian, 13 June 2025
Recommended Comments
Create an account or sign in to comment